Conference Recap
Conference Recap
Advances in Breast Cancer From AACR 2023
Therapies combining PARP plus PD-L1 inhibition, PARP inhibition plus chemotherapy, and whole tumor cell therapeutic vaccines are among breast...
Conference Recap
Key Takeaways in Early Breast Cancer From AACR 2023
A novel agent used to visualize positive margins in lumpectomy, the effect of race on skin toxicity in radiotherapy, and DCIS recurrence are key...
Conference Recap
Top Studies in Metastatic Breast Cancer From SABCS 2022
Top studies in metastatic breast cancer from SABCS 2022 focus on practice-changing therapies for HR+/HER2- breast cancer, a follow-up of the...
Conference Recap
Breakthroughs in Mantle Cell Lymphoma From ASH 2022
The beginning of the end for upfront stem cell transplants and chemotherapy, plus novel relapsed/refractory therapies, are among Dr Peter Martin's...
Conference Recap
Highlights in Breast Cancer From SITC 2022
Conference Recap
Advances in Non–Small Cell Lung Cancer From SITC 2022
The role of gene mutations in outcomes and treatment resistance, a novel LAG-3 inhibitor, and the case for neoadjuvant therapy are among the NSCLC...
Conference Recap
Highlights in Advanced Non–Small Cell Lung Cancer From ESMO 2022
Highlights in NSCLC from ESMO 2022 include sotorasib in KRAS G12C mutated disease, 5-year data on pembrolizumab, and novel treatment...
Conference Recap
Key Data on Early Non–Small Cell Lung Cancer From ESMO 2022
Osimertinib dosing periods, the use of ctDNA to predict recurrence, and the role of air pollution in promoting lung cancer are among...
Conference Recap
Highlights in Early Breast Cancer From the 2022 American Society of Clinical Oncology Annual Meeting
Highlights in early breast cancer from ASCO 2022 include results from NeoSTAR in triple-negative disease and 8-year follow-up of the ASTRRA study...
Conference Recap
Key Abstracts in Metastatic Breast Cancer From the 2022 American Society of Clinical Oncology Annual Meeting
Key abstracts in metastatic breast cancer from ASCO 2022 include "showstopper" results from DESTINY-Breast04 and benefit from sacituzumab...
Conference Recap
Highlights in Early-Stage Non–Small Cell Lung Cancer From ASCO 2022
The benefit of neoadjuvant immunotherapy in advanced non–small cell lung cancer and a real-world analysis of the importance of surgical quality...